Regulatory Compliance and Ethical Sourcing
In 2026, the sourcing of DBM is strictly governed by organizations like the AATB (American Association of Tissue Banks) and the FDA. Every DBM product must have "full traceability" from the donor to the recipient. This ensures that in the incredibly rare event of a safety concern, every patient who received tissue from that donor can be quickly identified.
Ethically, DBM is unique because it is a "gift of life" from tissue donors. In 2026, there is a strong emphasis on "respect for the gift," ensuring that no part of the donated tissue is wasted and that the processing honors the donor's intent. This ethical framework is essential for maintaining public trust in the allograft industry, which provides the raw material that makes these life-changing surgeries possible.